|
Tijdschrift beschrijving
Alle jaargangen van het bijbehorende tijdschrift
Alle afleveringen van het bijbehorende jaargang
Alle artikelen van de bijbehorende aflevering
197 gevonden resultaten
| nr | titel | auteur | tijdschrift | jaar | jaarg. | afl. | pagina('s) | type |
| 1 | Adalimumab |
2015 |
1554 | 1 |
p. 16 |
artikel |
||
| 2 | Adalimumab |
2015 |
1554 | 1 |
p. 14 |
artikel |
||
| 3 | Adalimumab |
2015 |
1554 | 1 |
p. 15 |
artikel |
||
| 4 | Adalimumab/etanercept/infliximab |
2015 |
1554 | 1 |
p. 17 |
artikel |
||
| 5 | Adefovir dipivoxil |
2015 |
1554 | 1 |
p. 18 |
artikel |
||
| 6 | Alendronic acid/zoledronic acid |
2015 |
1554 | 1 |
p. 19 |
artikel |
||
| 7 | Amlodipine |
2015 |
1554 | 1 |
p. 20 |
artikel |
||
| 8 | Amlodipine/atorvastatin |
2015 |
1554 | 1 |
p. 21 |
artikel |
||
| 9 | Amphotericin B |
2015 |
1554 | 1 |
p. 22 |
artikel |
||
| 10 | Anidulafungin/clofarabine/micafungin |
2015 |
1554 | 1 |
p. 23 |
artikel |
||
| 11 | Antihypertensives |
2015 |
1554 | 1 |
p. 24 |
artikel |
||
| 12 | Antimycobacterials |
2015 |
1554 | 1 |
p. 25 |
artikel |
||
| 13 | Antineoplastics/folinic acid |
2015 |
1554 | 1 |
p. 26 |
artikel |
||
| 14 | Antineoplastics/folinic acid |
2015 |
1554 | 1 |
p. 27 |
artikel |
||
| 15 | Antithymocyte globulin/methylprednisolone/prednisolone/tacrolimus |
2015 |
1554 | 1 |
p. 28 |
artikel |
||
| 16 | Antivirals |
2015 |
1554 | 1 |
p. 29 |
artikel |
||
| 17 | Apomorphine/levodopa |
2015 |
1554 | 1 |
p. 30 |
artikel |
||
| 18 | Aripiprazole/quetiapine |
2015 |
1554 | 1 |
p. 31 |
artikel |
||
| 19 | Aspirin |
2015 |
1554 | 1 |
p. 32 |
artikel |
||
| 20 | Aspirin |
2015 |
1554 | 1 |
p. 34 |
artikel |
||
| 21 | Aspirin |
2015 |
1554 | 1 |
p. 33 |
artikel |
||
| 22 | Aspirin |
2015 |
1554 | 1 |
p. 35 |
artikel |
||
| 23 | Aspirin/clopidogrel |
2015 |
1554 | 1 |
p. 36 |
artikel |
||
| 24 | Atomoxetine |
2015 |
1554 | 1 |
p. 38 |
artikel |
||
| 25 | Atomoxetine |
2015 |
1554 | 1 |
p. 37 |
artikel |
||
| 26 | BCG |
2015 |
1554 | 1 |
p. 39 |
artikel |
||
| 27 | BCG |
2015 |
1554 | 1 |
p. 40 |
artikel |
||
| 28 | Benznidazole/nifurtimox |
2015 |
1554 | 1 |
p. 41 |
artikel |
||
| 29 | Benzodiazepines/levomepromazine/opioids |
2015 |
1554 | 1 |
p. 42 |
artikel |
||
| 30 | Betamethasone |
2015 |
1554 | 1 |
p. 43 |
artikel |
||
| 31 | Bevacizumab/carboplatin/crizotinib/gemcitabine/paclitaxel |
2015 |
1554 | 1 |
p. 44 |
artikel |
||
| 32 | Bleomycin/cisplatin/epirubicin/etoposide |
2015 |
1554 | 1 |
p. 45 |
artikel |
||
| 33 | Botulinium toxin A |
2015 |
1554 | 1 |
p. 46 |
artikel |
||
| 34 | Buprenorphine abuse |
2015 |
1554 | 1 |
p. 47 |
artikel |
||
| 35 | Calcium gluconate/dexamethasone |
2015 |
1554 | 1 |
p. 48 |
artikel |
||
| 36 | Calcium hydroxylapatite |
2015 |
1554 | 1 |
p. 49 |
artikel |
||
| 37 | Capecitabine |
2015 |
1554 | 1 |
p. 50 |
artikel |
||
| 38 | Capecitabine |
2015 |
1554 | 1 |
p. 51 |
artikel |
||
| 39 | Carbamazepine |
2015 |
1554 | 1 |
p. 52 |
artikel |
||
| 40 | Carbimazole |
2015 |
1554 | 1 |
p. 53 |
artikel |
||
| 41 | Cefepime |
2015 |
1554 | 1 |
p. 54 |
artikel |
||
| 42 | Cefoperazone/vancomycin |
2015 |
1554 | 1 |
p. 55 |
artikel |
||
| 43 | Ceftolozane/tazobactam medication errors |
2015 |
1554 | 1 |
p. 1 |
artikel |
||
| 44 | Celecoxib/sodium bicarbonate |
2015 |
1554 | 1 |
p. 56 |
artikel |
||
| 45 | Cetuximab |
2015 |
1554 | 1 |
p. 57 |
artikel |
||
| 46 | Cetuximab |
2015 |
1554 | 1 |
p. 58 |
artikel |
||
| 47 | Chlorhexidine |
2015 |
1554 | 1 |
p. 59 |
artikel |
||
| 48 | Chorioamnionitis: uncommon AE following vaccinations in the US |
2015 |
1554 | 1 |
p. 7 |
artikel |
||
| 49 | Ciclosporin |
2015 |
1554 | 1 |
p. 60 |
artikel |
||
| 50 | Ciclosporin/dexamethasone/etoposide |
2015 |
1554 | 1 |
p. 61 |
artikel |
||
| 51 | Ciclosporin/mycophenolate mofetil |
2015 |
1554 | 1 |
p. 62 |
artikel |
||
| 52 | Cidofovir |
2015 |
1554 | 1 |
p. 63 |
artikel |
||
| 53 | Cisplatin |
2015 |
1554 | 1 |
p. 64 |
artikel |
||
| 54 | Cisplatin/gemcitabine |
2015 |
1554 | 1 |
p. 65 |
artikel |
||
| 55 | Cisplatin/gimeracil/oteracil/tegafur |
2015 |
1554 | 1 |
p. 66 |
artikel |
||
| 56 | Clevudine/entecavir/lamivudine |
2015 |
1554 | 1 |
p. 67 |
artikel |
||
| 57 | Clozapine |
2015 |
1554 | 1 |
p. 68 |
artikel |
||
| 58 | CMDh endorses advice on use of high-dose ibuprofen |
2015 |
1554 | 1 |
p. 2 |
artikel |
||
| 59 | Colchicine overdose |
2015 |
1554 | 1 |
p. 69 |
artikel |
||
| 60 | Cotrimoxazole |
2015 |
1554 | 1 |
p. 70 |
artikel |
||
| 61 | Cyclobenzaprine |
2015 |
1554 | 1 |
p. 71 |
artikel |
||
| 62 | Cyclophosphamide |
2015 |
1554 | 1 |
p. 72 |
artikel |
||
| 63 | Dexamethasone |
2015 |
1554 | 1 |
p. 73 |
artikel |
||
| 64 | Dexamethasone/lenalidomide |
2015 |
1554 | 1 |
p. 74 |
artikel |
||
| 65 | Dexamethasone/prednisone |
2015 |
1554 | 1 |
p. 75 |
artikel |
||
| 66 | Dexamethasone/thalidomide |
2015 |
1554 | 1 |
p. 76 |
artikel |
||
| 67 | Diazepam/oxycodone/paracetamol |
2015 |
1554 | 1 |
p. 77 |
artikel |
||
| 68 | Enfuvirtide |
2015 |
1554 | 1 |
p. 78 |
artikel |
||
| 69 | Enoxaparin sodium |
2015 |
1554 | 1 |
p. 80 |
artikel |
||
| 70 | Enoxaparin sodium |
2015 |
1554 | 1 |
p. 79 |
artikel |
||
| 71 | Entecavir/lamivudine/tenofovir disoproxil fumarate |
2015 |
1554 | 1 |
p. 81 |
artikel |
||
| 72 | Epidermal growth factor receptor antagonists/mitogen-activated protein kinase kinase inhibitors |
2015 |
1554 | 1 |
p. 82 |
artikel |
||
| 73 | Epoetin beta may increase risk of retinopathy of prematurity |
2015 |
1554 | 1 |
p. 3 |
artikel |
||
| 74 | Erlotinib |
2015 |
1554 | 1 |
p. 83 |
artikel |
||
| 75 | Erythromycin/trihexyphenidyl |
2015 |
1554 | 1 |
p. 84 |
artikel |
||
| 76 | Escitalopram |
2015 |
1554 | 1 |
p. 85 |
artikel |
||
| 77 | Etanercept |
2015 |
1554 | 1 |
p. 86 |
artikel |
||
| 78 | Etanercept |
2015 |
1554 | 1 |
p. 87 |
artikel |
||
| 79 | Ethyl fumarate |
2015 |
1554 | 1 |
p. 88 |
artikel |
||
| 80 | Extended DAPT after stenting increases risk of bleeding |
2015 |
1554 | 1 |
p. 8 |
artikel |
||
| 81 | Fampridine |
2015 |
1554 | 1 |
p. 89 |
artikel |
||
| 82 | Fingolimod |
2015 |
1554 | 1 |
p. 90 |
artikel |
||
| 83 | Flawed studies: EMA confirms recommendation to suspend drugs |
2015 |
1554 | 1 |
p. 4 |
artikel |
||
| 84 | Floxuridine/lobaplatin/pirarubicin |
2015 |
1554 | 1 |
p. 91 |
artikel |
||
| 85 | Fluconazole |
2015 |
1554 | 1 |
p. 92 |
artikel |
||
| 86 | Gabapentin |
2015 |
1554 | 1 |
p. 93 |
artikel |
||
| 87 | Ganciclovir |
2015 |
1554 | 1 |
p. 94 |
artikel |
||
| 88 | Gefitinib/panitumumab |
2015 |
1554 | 1 |
p. 95 |
artikel |
||
| 89 | Gemcitabine/vinorelbine |
2015 |
1554 | 1 |
p. 96 |
artikel |
||
| 90 | Gimeracil/oteracil/tegafur |
2015 |
1554 | 1 |
p. 97 |
artikel |
||
| 91 | Gimeracil/oteracil/tegafur/warfarin interaction |
2015 |
1554 | 1 |
p. 98 |
artikel |
||
| 92 | Ginkgo biloba/ginseng |
2015 |
1554 | 1 |
p. 99 |
artikel |
||
| 93 | Glatiramer acetate |
2015 |
1554 | 1 |
p. 100 |
artikel |
||
| 94 | Haloperidol/olanzapine/zuclopenthixol |
2015 |
1554 | 1 |
p. 101 |
artikel |
||
| 95 | Heparin/warfarin |
2015 |
1554 | 1 |
p. 102 |
artikel |
||
| 96 | Higher risk of hyperlipidaemia with olanzapine in Japan |
2015 |
1554 | 1 |
p. 9 |
artikel |
||
| 97 | Higher risks of VTE with newer combined OCs in the UK |
2015 |
1554 | 1 |
p. 10 |
artikel |
||
| 98 | Ibandronic acid |
2015 |
1554 | 1 |
p. 103 |
artikel |
||
| 99 | Ibuprofen |
2015 |
1554 | 1 |
p. 104 |
artikel |
||
| 100 | Ibuprofen/codeine phosphate abuse |
2015 |
1554 | 1 |
p. 105 |
artikel |
||
| 101 | Icatibant |
2015 |
1554 | 1 |
p. 106 |
artikel |
||
| 102 | Imatinib |
2015 |
1554 | 1 |
p. 107 |
artikel |
||
| 103 | Immune globulin |
2015 |
1554 | 1 |
p. 108 |
artikel |
||
| 104 | Immune globulin |
2015 |
1554 | 1 |
p. 109 |
artikel |
||
| 105 | Immunosuppressants |
2015 |
1554 | 1 |
p. 110 |
artikel |
||
| 106 | Infliximab |
2015 |
1554 | 1 |
p. 111 |
artikel |
||
| 107 | Infliximab |
2015 |
1554 | 1 |
p. 112 |
artikel |
||
| 108 | Infliximab/methotrexate/tacrolimus |
2015 |
1554 | 1 |
p. 113 |
artikel |
||
| 109 | Interferon-α-2b |
2015 |
1554 | 1 |
p. 114 |
artikel |
||
| 110 | Interferon-α/ribavirin |
2015 |
1554 | 1 |
p. 115 |
artikel |
||
| 111 | Interleukin 2 |
2015 |
1554 | 1 |
p. 116 |
artikel |
||
| 112 | Iohexol |
2015 |
1554 | 1 |
p. 117 |
artikel |
||
| 113 | Ipilimumab |
2015 |
1554 | 1 |
p. 118 |
artikel |
||
| 114 | Isoniazid |
2015 |
1554 | 1 |
p. 120 |
artikel |
||
| 115 | Isoniazid |
2015 |
1554 | 1 |
p. 119 |
artikel |
||
| 116 | Ketamine abuse |
2015 |
1554 | 1 |
p. 121 |
artikel |
||
| 117 | Lamivudine |
2015 |
1554 | 1 |
p. 122 |
artikel |
||
| 118 | Levamisole |
2015 |
1554 | 1 |
p. 123 |
artikel |
||
| 119 | Lormetazepam/verapamil overdose |
2015 |
1554 | 1 |
p. 124 |
artikel |
||
| 120 | Maprotiline overdose |
2015 |
1554 | 1 |
p. 125 |
artikel |
||
| 121 | Mercaptopurine/methotrexate |
2015 |
1554 | 1 |
p. 126 |
artikel |
||
| 122 | Metformin |
2015 |
1554 | 1 |
p. 127 |
artikel |
||
| 123 | Metformin |
2015 |
1554 | 1 |
p. 128 |
artikel |
||
| 124 | Methotrexate |
2015 |
1554 | 1 |
p. 129-130 |
artikel |
||
| 125 | Methylprednisolone |
2015 |
1554 | 1 |
p. 130 |
artikel |
||
| 126 | Methylprednisolone/tacrolimus |
2015 |
1554 | 1 |
p. 131 |
artikel |
||
| 127 | Metoprolol |
2015 |
1554 | 1 |
p. 132 |
artikel |
||
| 128 | Minoxidil |
2015 |
1554 | 1 |
p. 133 |
artikel |
||
| 129 | Mycophenolate mofetil/prednisolone/tacrolimus |
2015 |
1554 | 1 |
p. 134 |
artikel |
||
| 130 | Natalizumab |
2015 |
1554 | 1 |
p. 135 |
artikel |
||
| 131 | Natalizumab |
2015 |
1554 | 1 |
p. 136 |
artikel |
||
| 132 | Olanzapine/paliperidone |
2015 |
1554 | 1 |
p. 137 |
artikel |
||
| 133 | Olanzapine/quetiapine/risperidone |
2015 |
1554 | 1 |
p. 138 |
artikel |
||
| 134 | Omeprazole |
2015 |
1554 | 1 |
p. 139 |
artikel |
||
| 135 | Pamidronic acid |
2015 |
1554 | 1 |
p. 140 |
artikel |
||
| 136 | Panitumumab |
2015 |
1554 | 1 |
p. 141 |
artikel |
||
| 137 | Paracetamol |
2015 |
1554 | 1 |
p. 142 |
artikel |
||
| 138 | Paracetamol reduces testosterone production in xenograft model |
2015 |
1554 | 1 |
p. 11 |
artikel |
||
| 139 | Pegaspargase |
2015 |
1554 | 1 |
p. 143 |
artikel |
||
| 140 | Peginterferon-α |
2015 |
1554 | 1 |
p. 144 |
artikel |
||
| 141 | Peginterferon-α-2a/ribavirin/simeprevir |
2015 |
1554 | 1 |
p. 145 |
artikel |
||
| 142 | Peginterferon/ribavirin |
2015 |
1554 | 1 |
p. 146 |
artikel |
||
| 143 | Perfluorocarbon |
2015 |
1554 | 1 |
p. 147 |
artikel |
||
| 144 | Pergolide |
2015 |
1554 | 1 |
p. 148 |
artikel |
||
| 145 | Piribedil |
2015 |
1554 | 1 |
p. 149 |
artikel |
||
| 146 | Polystyrenes/quetiapine/sevelamer interaction |
2015 |
1554 | 1 |
p. 150 |
artikel |
||
| 147 | Povidone iodine |
2015 |
1554 | 1 |
p. 151 |
artikel |
||
| 148 | Prednisone |
2015 |
1554 | 1 |
p. 152 |
artikel |
||
| 149 | Propranolol |
2015 |
1554 | 1 |
p. 153 |
artikel |
||
| 150 | Quetiapine/tropatepine |
2015 |
1554 | 1 |
p. 154 |
artikel |
||
| 151 | Rituximab |
2015 |
1554 | 1 |
p. 155 |
artikel |
||
| 152 | Rituximab |
2015 |
1554 | 1 |
p. 158 |
artikel |
||
| 153 | Rituximab |
2015 |
1554 | 1 |
p. 156 |
artikel |
||
| 154 | Rituximab |
2015 |
1554 | 1 |
p. 157 |
artikel |
||
| 155 | Romiplostim |
2015 |
1554 | 1 |
p. 159 |
artikel |
||
| 156 | Rosuvastatin |
2015 |
1554 | 1 |
p. 160 |
artikel |
||
| 157 | Roxithromycin |
2015 |
1554 | 1 |
p. 161 |
artikel |
||
| 158 | Sodium valproate overdose |
2015 |
1554 | 1 |
p. 162 |
artikel |
||
| 159 | Sofosbuvir, daclatasvir, ledipsavir: interactions with amiodarone |
2015 |
1554 | 1 |
p. 5 |
artikel |
||
| 160 | Sorafenib |
2015 |
1554 | 1 |
p. 164 |
artikel |
||
| 161 | Sorafenib |
2015 |
1554 | 1 |
p. 163 |
artikel |
||
| 162 | Sotalol |
2015 |
1554 | 1 |
p. 165 |
artikel |
||
| 163 | Statins increase likelihood of diabetes and obesity |
2015 |
1554 | 1 |
p. 12 |
artikel |
||
| 164 | Sulfasalazine |
2015 |
1554 | 1 |
p. 166 |
artikel |
||
| 165 | Tacrolimus |
2015 |
1554 | 1 |
p. 167 |
artikel |
||
| 166 | Tadalafil |
2015 |
1554 | 1 |
p. 168 |
artikel |
||
| 167 | Telaprevir |
2015 |
1554 | 1 |
p. 169 |
artikel |
||
| 168 | Tenofovir disoproxil fumarate |
2015 |
1554 | 1 |
p. 170 |
artikel |
||
| 169 | Teriparatide |
2015 |
1554 | 1 |
p. 171 |
artikel |
||
| 170 | Testosterone |
2015 |
1554 | 1 |
p. 172 |
artikel |
||
| 171 | TGA: insufficient data for natalizumab-related melanoma |
2015 |
1554 | 1 |
p. 6 |
artikel |
||
| 172 | Theophylline overdose |
2015 |
1554 | 1 |
p. 173 |
artikel |
||
| 173 | Thiamazole |
2015 |
1554 | 1 |
p. 175 |
artikel |
||
| 174 | Thiamazole |
2015 |
1554 | 1 |
p. 174 |
artikel |
||
| 175 | Topiramate |
2015 |
1554 | 1 |
p. 176 |
artikel |
||
| 176 | Trabectedin |
2015 |
1554 | 1 |
p. 177 |
artikel |
||
| 177 | Tranexamic acid |
2015 |
1554 | 1 |
p. 178 |
artikel |
||
| 178 | Transdermal buprenorphine: lower fracture burden at acceptable cost |
2015 |
1554 | 1 |
p. 13 |
artikel |
||
| 179 | Trastuzumab |
2015 |
1554 | 1 |
p. 181 |
artikel |
||
| 180 | Trastuzumab |
2015 |
1554 | 1 |
p. 179 |
artikel |
||
| 181 | Trastuzumab |
2015 |
1554 | 1 |
p. 180 |
artikel |
||
| 182 | Trastuzumab emtansine |
2015 |
1554 | 1 |
p. 182 |
artikel |
||
| 183 | Triamcinolone |
2015 |
1554 | 1 |
p. 184 |
artikel |
||
| 184 | Triamcinolone |
2015 |
1554 | 1 |
p. 183 |
artikel |
||
| 185 | Triclofos |
2015 |
1554 | 1 |
p. 185 |
artikel |
||
| 186 | Ustekinumab |
2015 |
1554 | 1 |
p. 186 |
artikel |
||
| 187 | Vancomycin |
2015 |
1554 | 1 |
p. 187 |
artikel |
||
| 188 | Vemurafenib |
2015 |
1554 | 1 |
p. 190 |
artikel |
||
| 189 | Vemurafenib |
2015 |
1554 | 1 |
p. 188 |
artikel |
||
| 190 | Vemurafenib |
2015 |
1554 | 1 |
p. 189 |
artikel |
||
| 191 | Vismodegib |
2015 |
1554 | 1 |
p. 192 |
artikel |
||
| 192 | Vismodegib |
2015 |
1554 | 1 |
p. 191 |
artikel |
||
| 193 | Warfarin |
2015 |
1554 | 1 |
p. 193 |
artikel |
||
| 194 | Warfarin |
2015 |
1554 | 1 |
p. 194 |
artikel |
||
| 195 | Warfarin overdose |
2015 |
1554 | 1 |
p. 195 |
artikel |
||
| 196 | Zoledronic Acid |
2015 |
1554 | 1 |
p. 196 |
artikel |
||
| 197 | Zonisamide |
2015 |
1554 | 1 |
p. 197 |
artikel |
197 gevonden resultaten